Rosetta Genomics (ROSG) Misses Q1 EPS by 2c

Rosetta Genomics (NASDAQ: ROSG) reported Q1 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $3.36 million.

For earnings history and earnings-related data on Rosetta Genomics (ROSG) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
• Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan